title: Sudden Cardiac Death and Disorders of the QT Interval: Anesthetic Implications and Focus on Perioperative Management.
authors.affiliation: Department of Anesthesiology, Mayo Clinic, Scottsdale, Arizona.
authors.forename: Harish
authors.initials: H
authors.lastname: Ramakrishna
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona.
authors.forename: Meabh
authors.initials: M
authors.lastname: O'Hare
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona.
authors.forename: Farouk
authors.initials: F
authors.lastname: Mookadam
authors.affiliation: Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
authors.forename: Jacob T
authors.initials: JT
authors.lastname: Gutsche
authors.affiliation: Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
authors.forename: Ronak
authors.initials: R
authors.lastname: Shah
authors.affiliation: Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: yiandoc@hotmail.com.
authors.forename: John G T
authors.initials: JG
authors.lastname: Augoustides
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects; D000777:Anesthetics / Q000008:administration & dosage* / Q000009:adverse effects; D016757:Death, Sudden, Cardiac / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology*; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000009:adverse effects; D019990:Perioperative Care / Q000379:methods*
chemical_list: D000701:Analgesics, Opioid; D000777:Anesthetics; D009125:Muscle Relaxants, Central
keywords: Bazett formula; Brugada syndrome; QT interval; amiodarone; automated implanted cardiac defibrillator; beta-blockers; cardiac ion channelopathy; long QT syndrome; magnesium; pacemaker; quinidine; short QT syndrome; sotalol; torsades de pointes; transmural repolarization; voltage-gated sodium channel